Project Description
Productos Gutis S.A. (Gutis, or the company), a Costa Rican pharmaceutical company, is undertaking a US$14.5 million project to expand into and to modernize its operation in a relocated facility on the outskirts of San Jose. The new plant will be equipped with modern production equipment that will increase capacity and product lines. Existing warehouses are now scattered throughout the city. They will also be consolidated at this new location. The proposed investment is part of Gutis''s strategy to improve sales and margins by reducing dependence on government business, increasing its share in the private market, increasing exports, and obtaining Good Manufacturing Practice (GMP) certification from regulatory agencies such as the World Health Organization (WHO) and the United States Food and Drug Administration (FDA).